PPD, Inc. and Global Allergy and Asthma European Network (GA2LEN) Announce Strategic Alliance in Allergic Diseases

WILMINGTON, N.C., & BERLIN, Germany--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the network’s allergy and asthma experts and to more than 100 allergy and asthma sites in Europe.

MORE ON THIS TOPIC